Mark Hancock sells multiple PACS tranches (PACS) via Citigroup
Rhea-AI Filing Summary
Mark Hancock reported multiple sales of Common stock of PACS under a Form 144 filing. The filing lists several dispositions between 06/15/2026 and 07/02/2026, including transactions of 153,254 shares on 06/15/2026 and 138,069 shares on 06/25/2026.
The sales list per‑trade proceeds in dollars alongside share counts and identify Citigroup Global Markets Inc at 388 Greenwich Street as the broker. The filing also shows an earlier block of 54,626,199 shares described as "shares acquired at formation of the issuer" dated 03/01/2023.
Positive
- None.
Negative
- None.
Insights
Multiple Rule 144 dispositions by a single holder, documented with per‑trade shares and proceeds.
The filing records discrete sales by Mark Hancock on specified dates with exact share counts and sale proceeds, which is consistent with a Rule 144 disclosure of restricted/controlled securities being resold through a broker. The excerpt names Citigroup Global Markets Inc as the selling broker.
Key dependencies include the holder's holding period and satisfaction of Rule 144 conditions; the excerpt documents the transactions but does not restate the resale conditions. Subsequent public filings or broker records would show execution details.
Transaction sizes are individually material to a retail cap but not aggregated here; per‑trade data provides transparency on timing and scale.
The record lists several mid‑to‑large tranches such as 153,254 shares for $5,568,759.95 and 138,069 shares for $5,567,701.46. These line items show realized proceeds per trade and trading cadence over a two‑week period.
Market impact depends on total float and daily volume, which are not provided in the excerpt; filings that disclose outstanding shares would enable assessment of relative scale. Cash‑flow treatment indicates proceeds to the selling holder per the listed dollar amounts.